TRADING LEVELS FOR 23rd May 2007

[tryme me]

Sharp 9.55 grab AMTEK AUTO & WATCH EXPLOSION.

Attn Future Traders and Day Traders : Go back to last week of November … Yes we recommended Aurobindo for December futures saying “Only Pharma stock for December futures … Aurobindo Pharma” At that time it exploded from 610 to 692 … Now again we repeat … our old hot favourite pharma stock again … Grab in May futures …if u want to earn a fortune then just grab this jackpot at the opening bell …. Big positive announcements since last few weeks + One side buying by leading fund (who ..?? we know … but cannot reveal) + Great results + Huge short covering will create an explosion in Aurobindo Pharma. Stock from the current price of Rs. 716 shall non-stop rally to Rs. 732 and Rs. 751 …!!! Crossover and close above this will take the stock to Rs. 780 mark …!!! Forget Sensex movement … Just buy 25 … 50 … 100 lots at 09:55 am …!!! Just do not miss … Real Jackpot …!!!

Aurobindo Pharma Lot Size – 350 Last close – Rs. 716 Aurobindo Pharma is the largest manufacturer of semi-synthetic penicillins in Asia and is the fourth largest in the world. Cumulatively, the company has filed a total of 89 DMFs (Drug Master Files), of which 45 are with US FDA and 44 in EU. We very strongly recommend to grab this jackpot in May futures at the opening bell … Expect a huge spurt in this stock starting today itself …!!! A look at some of the fundamentals + announcements … On an equity base of just Rs. 26.63 crores the company has declared unbelievable mind boggling results for the quarter ended December 2006, a net profit of Rs 60.12 crores for the quarter ended December 31, 2006 as compared to just Rs 26.1 crores for the quarter ended December 31, 2006 . A huge jump of more than 130 % in net profit …!!! Regularly since last few months the company is declaring positive announcements regarding product approvals abroad and recently the company declared taking over of a pvt co called Senor Organics and disinvestment of China subsidiary … !!! Other major announcements which have caught the fund manager's attention are .. - USFDA Approval for its Zolpidem brand which enjoys a market of around $2.1 billion in the USA …!!! - Ninth approval from MCC South Africa for Citalopram which will enable the company to participate in CNS segment of South African market, which is a fast growing sector. Citalopram today commands a market of 56mio USD in South Africa …!!! - Approval from MEB Netherlands for Lisinopril Tablets of Aurobindo which has a European market of over 300 mio US dollars …!!! - Cephazone, cephalosporin sterile injectable facility in California , got approval by USFDA & approval of Ceftriaxone from USFDA …!!! These are major positives for the company …!!! With just 6 % of the equity with Indian public and huge quantities of shares with FIIs like Morgan, Goldman, Merrill, FID Mauritius etc Fund Managers view all above approvals as a billion dollar business abroad …!!! Yes our research team and network indicates somebody .. somewhere has bought huge quantity of this stock in delivery and futures .. Who ??? We cannot reveal … Fundamentals say stock is still going very cheap at current levels … Charts indicate that t echnically stock is ready to explode non-stop to Rs. 731 and Rs. 754 shortly … Grab this stock at the opening bell and do not sell single share till it achieves all our upper targets … Above 754 stock will kiss the Rs. 780 mark in futures …So just grab this stock at the opening bell and enjoy the rally …!!!

NOTE : This commentary is not a recommendation to buy or sell. Use at your own risk.

Disclosures : At the time of writing this article, author, his clients & dependent family members may have positions in the stocks mentioned above. The author, his firm, his clients or any of his dependent family members may make purchases or sale of the securities mentioned in website. Author may have positions in above stocks so have vested interest obviously in their going up or down as the case may be.

Disclaimer : Investing in any equity is risky. Our recommendations are based on reliable & authenticated sources believed to be true & correct, and also is technical analysis based on & conceived from charts. Investors should take their own decisions. We assume no responsibility for any transactions undertaken by them. The author won't be liable or responsible for any legal or financial losses made by anybody.

---

Looking for a deal? Find great prices on flights and hotels with Yahoo! FareChase.